Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Investment activity across the region is also increasing as pharmaceutical manufacturers scale production and clinical development programs, reinforcing North Americas position as the primary hub for obesity pharmacotherapy development and commercialization
GLP-1 medications were originally developed to help manage type 2 diabetes and improve heart and kidney health, though they are now sometimes used to help treat obesity and promote weight loss as well
Mol Cancer 21(1):104 Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, Li X (2009) Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation
doi: 10.2147/CLEP.S91125 35 World health organization collaborating centre for drug statistics methodology
US$ 25.71
US$ 22.37
US$ 24.12
US$ 20.33
US$ 24.89
US$ 22.90
